As CA11 is a ligand for neurexin, and glioma cells also express some types of neurotrophin receptors (Johnston et al., 2007; Wiesenhofer et al., 2000), it is possible that secreted CA11 binds to these receptors to modulate downstream signaling pathways. The gene discussed is CA11; the disease is glioma.